Moderna announces early results of it's vaccine using mRNA. Phase 3 study with 30,000 patients. 90 in placebo arm developed covid while only 5 in the mRNA group indicating a 94.5% vaccine efficacy. Link to Moderna PDF. #coronavirus
Reply to this Note | Notes Linking Here | Moderna Vaccine
Risks and benefits of ERCP discussed with patient including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Patient agreeable to proceed with ERCP.
...Read more
Risks and benefits of ERCP discussed with patient including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Patient agreeable to proceed with ERCP. Hand out describing procedure given to patient.
...Read more
Risks and benefits of ERCP discussed with patient including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient.
Patient agreeable to proceed with ERCP.[]
...Read more
Choledocholithiasis - Risks and benefits of ERCP discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient.
Patient agreeable to proceed with ERCP.[]
...Read more
Bile leak - Risks and benefits of ERCP with stent discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient.
Patient agreeable to proceed with ERCP. Patient agreeable to follow up for repeat ERCP in 6 weeks if stent placed[].
...Read more
"parenteral methotrexate at
a dose of 25 mg / week is e
ective for steroid-dependent and
steroid-refractory CD" Moderate to Severe Crohn's disease treatment
...Read more
Choledocholithiasis - Risks and benefits of ERCP discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient. Patient agreeable to proceed with ERCP.[]
...Read more
[] []male presented with [] abdominal pain for [] days. Associated nausea/vomiting. [] fever/chills.
Choledocholithiasis - Risks and benefits of ERCP discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient. Patient agreeable to proceed with ERCP.
...Read more
Choledocholithiasis - elevated liver enzymes, elevated bilirubin, epigastric[] abdominal pain, probable ascending cholangitis[]. Risks and benefits of Endoscopic Retrograde Cholangio-Pancreatography (ERCP) discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient.
Patient agreeable to proceed with ERCP.[]
...Read more
Choledocholithiasis - elevated liver enzymes, elevated bilirubin, epigastric[] abdominal pain, probable ascending cholangitis[]. Risks and benefits of Endoscopic Retrograde Cholangio-Pancreatography (ERCP) discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient.
Patient agreeable to proceed with ERCP.[] ERCP CPT codes. 43261 - ERCP. 43262 - ERCP with sphincterotomy. 43264 ERCP with stone removal
...Read more